Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance. Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications. We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, available data suggest that MGF-driven restoration of redox homeostasis represents a central mechanistic axis of its antitumor activity, rather than merely a downstream branch of apoptosis (84,85).”
From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [84]
In the citing paper
“Activation of oncogenes, aberrant metabolism, mitochondrial dysfunction, and loss of the tumor suppressor p53 can all promote increased ROS accumulation in cancer cells 69.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [69]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379 · cited 1×
“It has been observed that a small subpopulation of primary cancer cells expressing stem-cell markers was resistant to certain chemotherapeutic agents and radiatio”
BackgroundSchafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587 · cited 1×
“A moderate increase in ROS can promote cell proliferation and differentiatio”
BackgroundFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488 · cited 1×
“By exploiting the genetic differences between normal cells and cancer cells, several molecular-targeted drugs, such as imatinib (Gleevec; Novartis) and trastuzumab (Herceptin; Genentech/Roche), show promising therapeutic activity and few toxic side effect”
BackgroundCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429 · cited 1×
“Redox status in cancer stem cells Recurrence of cancer after chemotherapy or radiotherapy is initiated by a subpopulation of residual malignant cells that are highly resistant to treatment and which are believed to be cancer-initiating cells or cancer stem cell”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555 · cited 1×
“Recent studies showed that normal haemopoietic stem cells and normal mammary epithelial stem cells maintained ROS at lower levels than their mature progeny to prevent cellular differentiation and maintain long-term self-renewa”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272 · cited 1×
“This is consistent with the high incidence of p53 mutation or loss of p53 function in over 50% of human cancer”
Background
Research works printed but not linked: 1
- Kim, G. J., Chandrasekaran, K. & Morgan, W. F. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis 21, 361–367 (2006). · DOI · Paper page
Cited by
Items 501–600 of 1,014
Cytotoxicity and Oxidative Damage Induced by Halobenzoquinones to T24 Bladder Cancer Cells
Du, H., Li, J., Moe, B., McGuigan, C. F., Shen, S., & Li, X. (2013) · Environmental Science & Technology · doi:10.1021/es303762p · Cited by 145
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma
Agnihotri, S., Golbourn, B., Huang, X., Remke, M., Younger, S., Cairns, R. A., Chalil, A., Smith, C. A., Krumholtz, S.-L., Mackenzie, D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3079 · Cited by 139
“Cancer cells increase aerobic glycolysis through the Warburg effect and produce higher levels of oxidative stress via ROS(14,36).”
BackgroundLiu, Y., Liu, X., Guo, Z., Hu, Z., Xue, Z., & Lu, X. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.015 · Cited by 141
“It is closely related to people’s safety and health (Zhang et al., 2013; Trachootham et al., 2009).”
BackgroundAzimi, I., Petersen, R. M., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15474-7 · Cited by 137
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 148
Sun, J. F., Cai, X., Yung, M. M. H., Zhou, W., Li, J., Zhang, Y., Li, Z., Liu, S. S., Cheung, A., Ngan, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0459-x · Cited by 145
RetractedFenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy
Meng, X., Zhang, X., Liu, M., Cai, B., He, N., & Wang, Z. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100864 · Cited by 150
Pan, J.-X., Ding, K., & Wang, C.-Y. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10290 · Cited by 138
Duan, D., Zhang, B., Yao, J., Liu, Y., Sun, J., Ge, C., Peng, S., & Fang, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.027 · Cited by 145
Zou, P., Chen, M., Ji, J., Chen, W., Chen, X., Ying, S., Zhang, J., Zhang, Z., Liu, Z., Yang, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5364 · Cited by 140
“As a result, cancer cells are unable to cope with additional oxidative stress and become vulnerable to ROS [7, 27].”
BackgroundPiperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer
Zou, P., Xia, Y., Ji, J., Chen, W., Zhang, J., Chen, X., Rajamanickam, V., Chen, G., Wang, Z., Chen, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.058 · Cited by 154
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 151
“Approaches tomaximally exploit ROS-mediated cell death by combining drugs that induce ROS generation with compounds that suppress cellular antioxidant capacity have been proposed years ago (7).”
BackgroundGu, H., Mu, S., Qiu, G., Liu, X., Zhang, L., Yuan, Y., & Astruc, D. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.03.013 · Cited by 147
Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review
Yang, Z., Huang, S., Zhou, D.-D., Xiong, R.-G., Zhao, C., Fang, A., Zhang, Y., Li, H., & Zhu, H. (2022) · Antioxidants · doi:10.3390/antiox11081481 · Cited by 322
“ROS may exert cytotoxic effects on cancer cells, leading to malignant cell death, thereby limiting cancer progression [118,119].”
BackgroundPrecise modulation and use of reactive oxygen species for immunotherapy
Li, X., Gao, J., Wu, C., Wang, C., Zhang, R., He, J., Xia, Z. J., Joshi, N., Karp, J. M., & Kuai, R. (2024) · Science Advances · doi:10.1126/sciadv.adl0479 · Cited by 164
“Inspired by this phenomenon, several ROS-generating biomaterials have been developed to combat viruses, bacteria, and even cancer cells, which are vulnerable to increased ROS levels due to their reduced antioxidant enzyme activity ( 1 ) compared to healthy cells ( 5 , 6 ).”
BackgroundMitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
Blackman, R. K., Cheung-Ong, K., Gebbia, M., Proia, D. A., He, S., Kepros, J., Jonneaux, A., Marchetti, P., Kluza, J., Rao, P. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029798 · Cited by 135
“Increased levels of ROS and an altered redox status have long been observed in cancer cells”
BackgroundPoli, V., & Camporeale, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00121 · Cited by 137
“In particular, oxidative damage triggered by enhanced ROS accumulation is a prominent effect of both ionizing radiation and pharmacological agents such as gemcitabine, cisplatin, doxorubicin, and elesclomol (75).”
BackgroundManganese superoxide dismutase promotes anoikis resistance and tumor metastasis
Kamarajugadda, S., Cai, Q., Chen, H., Nayak, S., Zhu, J., He, M., Jin, Y., Zhang, Y., Ai, L., Martin, S. S., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.20 · Cited by 140
“the deleterious effect of ROS, cells are equipped with antioxidant systems to detoxify ROS and prevent them from accumulating at high concentrations.(9) The mitochondrialocated manganese superoxide dismutase (MnSOD, or SOD2) efficiently converts superoxide to the less reactive hydrogen peroxide that may break down fur…”
BackgroundInfluentialSelenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic
Ren, X., Zou, L., Lu, J., & Holmgren, A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.081 · Cited by 152
Zhou, Z., Ni, K., Deng, H., & Chen, X. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.006 · Cited by 145
Chen, T., Zeng, W., Tie, C., Yu, M., Hao, H., Deng, Y., Li, Q., Zheng, H., Wu, M., & Mei, L. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.016 · Cited by 150
“Redox homeostasis is of great significance to maintain the various normal physiological functions of the organism [1].”
BackgroundCancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 144
“Cancer cells establish robust antioxidant systems to thrive following oxidative damage (Gorrini et al., 2013; Trachootham et al., 2009).”
BackgroundThe functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer
Christiansen, A. B., & Dyrskjøt, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.12.013 · Cited by 152
“As cells in advanced tumors frequently exhibit high levels of oxidative stress [33], this could explain the nuclear localization of KPNA2.”
Rai, P., Young, J. J., Burton, D. G. A., Giribaldi, M. G., Önder, T. T., & Weinberg, R. A. (2010) · Oncogene · doi:10.1038/onc.2010.520 · Cited by 141
“, 2007), likely through imbalances in their antioxidant pathways (Trachootham et al., 2009) (Supplementary Figure S1).”
BackgroundKilling cancer with platycodin D through multiple mechanisms
Khan, M. N., Maryam, A., Zhang, H., Mehmood, T., & Ma, T. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12749 · Cited by 138
Zhang, F., Liang, X., Zhang, W., Wang, Y., Wang, H., Mohammed, Y., Song, B., Zhang, R., & Yuan, J. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.09.067 · Cited by 140
“Increased generation of reactive oxygen species (ROS), including HOCl, has long been observed in cancer cells, while the HOCl generation during cancer chemotherapy is less clear (Trachootham et al. 2009).”
BackgroundXiang, L., Xu, X., Zhang, S., Cai, D., & Dai, X. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.001 · Cited by 138
Nie, X., Xia, L., Wang, H., Chen, G., Wu, B., Zeng, T., Hong, C., Wang, L., & You, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b11291 · Cited by 140
Detection strategies for superoxide anion: A review
Jie, Z., Liu, J., Shu, M., Ying, Y., & Yang, H. (2021) · Talanta · doi:10.1016/j.talanta.2021.122892 · Cited by 148
Ju, H.-Q., Gocho, T., Aguilar, M., Wu, M., Zhuang, Z.-N., Fu, J., Yanaga, K., Huang, P., & Chiao, P. J. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0420 · Cited by 137
“When ROS accumulates past the detoxification capacity of the cell, ROS cytotoxicity damages mitochondria and cell membranes causing cell death (11, 12).”
BackgroundSelf-citationBernstein, S. H., Venkatesh, S., Li, M., Lee, J., Lu, B., Hilchey, S. P., Morse, K. M., Metcalfe, H. M., Skalska, J., Andreeff, M., et al. (2012) · Blood · doi:10.1182/blood-2011-02-340075 · Cited by 138
Metabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., García-Prieto, C., & Huang, P. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10267 · Cited by 151
Self-citationCancer biomarker discovery: Current status and future perspectives
Mäbert, K., Cojoc, M., Peitzsch, C., Kurth, I., Souchelnytskyi, S., & Dubrovska, A. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892229 · Cited by 154
“Th e increase in ROS production in cancer cells results in development of the adaptations to a redox stress, such as an upregulation of antioxidant capacity enabling the cells to maintain the ROS levels below the toxic threshold (Trachootham et al. 2009, Dang 2012).”
BackgroundLeone, A., Roca, M. S., Ciardiello, C., Costantini, S., & Budillon, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2597581 · Cited by 143
“(VDAC) or aquaporin, or by small vesicles such as exosomes [3, 5, 7].”
InfluentialSelenium Cytotoxicity in Cancer
Wallenberg, M., Misra, S., & Björnstedt, M. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12207 · Cited by 145
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases
Barrera, G., Pizzimenti, S., Ciamporcero, E. S., Daga, M., Ullio, C., Arcaro, A., Cetrangolo, G. P., Ferretti, C., Dianzani, C., Lepore, A., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6166 · Cited by 130
“In contrast, in several tumor types, the progression of malignancy is accompanied by reductions of oxidative stress, due to the upregulation of antioxidant capacity (199), and the induction of the Nfr2/Keap1 pathway, which negatively regulates the HNE intracellular concentration (151).”
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
Shen, H. M., Hau, E. K. C., Joshi, S. M., Dilda, P. J., & McDonald, K. L. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0247 · Cited by 142
“As ROS are synthesized during mitochondrial respiration, an increased rate of mitochondrial oxidation might exacerbate the ROS-induced DNA damage caused by radiotherapy (42, 43).”
BackgroundPeng, S., Zhang, B., Meng, X., Yao, J., & Fang, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00410 · Cited by 141
Tohme, S. T., Yazdani, H. O., Liu, Y., Loughran, P., van der Windt, D. J., Huang, H., Simmons, R. L., Shiva, S., Tai, S., & Tsung, A. (2017) · Hepatology · doi:10.1002/hep.29184 · Cited by 138
“Intracellular reactive oxygen species (ROS) production, a consequence of mitochondrial dysfunction when biogenesis is impaired, can induce apoptosis in cancer cells.((23)) Indeed, there was a significant increase in accumulation of ROS (Supporting Fig.”
BackgroundPeptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
Zhang, C., Wu, W. H., Li, R., Qiu, W., Zhuang, Z., Cheng, S., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804492 · Cited by 137
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
Zhang, C., Gao, F., Wu, W., Qiu, W., Zhang, L., Li, R., Zhuang, Z., Yu, W., Cheng, H. L., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04315 · Cited by 138
Programming DNA Nanoassembly for Enhanced Photodynamic Therapy
Pan, M., Jiang, Q., Sun, J., Xu, Z., Zhou, Y., Zhang, L., & Liu, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201912574 · Cited by 137
Dual effect of oxidative stress on leukemia cancer induction and treatment
Udensi, U. K., & Tchounwou, P. B. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0106-5 · Cited by 135
“For instance when the intrinsic stress that is already present in malignant cells is doubled by the treatmentinduced OS malignant cells can be sensitized to mainstay treatments or initiate the apoptotic pathway [31].”
BackgroundSoenen, S. J. H., & De Cuyper, M. (2009) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.282 · Cited by 134
Maurya, A. K., & Vinayak, M. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3921-7 · Cited by 143
Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance
Ryoo, I.-G., Lee, S.-H., & Kwak, M.-K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2428153 · Cited by 132
“As a result of these systems, malignant transformed cells can utilize ROS as a signal for tumor progression and metastasis [5, 14].”
BackgroundBoxem, W. V., der Paal, J. V., Gorbanev, Y. Y., Vanuytsel, S., Smits, E., Dewilde, S., & Bogaerts, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-16758-8 · Cited by 135
A Graphdiyne Oxide‐Based Iron Sponge with Photothermally Enhanced Tumor‐Specific Fenton Chemistry
Min, H., Qi, Y., Zhang, Y., Han, X., Cheng, K., Liu, Y., Liu, H., Hu, J., Nie, G., & Li, Y. (2020) · Advanced Materials · doi:10.1002/adma.202000038 · Cited by 135
Liu, B., & Thayumanavan, S. (2020) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2020.100271 · Cited by 153
Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
Cardaci, S., Desideri, E., & Ciriolo, M. R. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9422-7 · Cited by 140
Chang, J., Li, H., Hou, T., Duan, W., & Li, F. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.01.007 · Cited by 136
He, Z., Xu, Q., Newland, B., Foley, R., Lara‐Sáez, I., Curtin, J. F., & Wang, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00728a · Cited by 137
Selenium induces a multi‐targeted cell death process in addition to ROS formation
Wallenberg, M., Misra, S., Wasik, A. M., Marzano, C., Björnstedt, M., Gandin, V., & Fernandes, A. P. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12214 · Cited by 144
“The extracellular and intracellular thiol content are known to be elevated in many tumour types and the higher levels of thiols confer resistance against several chemotherapeutic drugs via thiol conjugation and detoxification [12].”
BackgroundKansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 143
Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., & Offidani, A. (2022) · Antioxidants · doi:10.3390/antiox11040612 · Cited by 132
“Indeed, despite cancer cells adapting to this condition by developing strong antioxidant mechanisms, they maintain higher ROS levels compared to normal cells [94].”
BackgroundBertrand, R. L. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.02.017 · Cited by 139
Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect
Ivanova, D., Zhelev, Z., Getsov, P. G., Nikolova, B., Aoki, I., Higashi, T., & Bakalova, R. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.013 · Cited by 137
Honeychurch, J., Alduaij, W., Azizyan, M., Cheadle, E. J., Pelicano, H., Ivanov, A., Huang, P., Cragg, M. S., & Illidge, T. M. (2012) · Blood · doi:10.1182/blood-2011-12-395541 · Cited by 131
Self-citationGong, K., Xie, J., Yi, H., & Li, W. (2012) · Biochemical Journal · doi:10.1042/bj20111685 · Cited by 134
From birth to death: A role for reactive oxygen species in neuronal development
Wilson, C., Muñoz-Palma, E., & González-Billault, C. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.09.012 · Cited by 129
Pathophysiological importance of aggregated damaged proteins
Höhn, A., Jung, T., & Grune, T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.028 · Cited by 138
Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer
Zhang, L., Li, J., Zong, L., Chen, X., Chen, K., Jiang, Z., Nan, L., Li, X., Li, W., Shan, T., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1616781 · Cited by 126
“Besides, ROS can also be produced in the mitochondria by electron transport chain (ETC) complexes I, II, and III, in which the electron leaked from the respiratory chain may react with molecular oxygen [7–9].”
BackgroundMitochondrial Dysfunction and Redox Imbalance as a Diagnostic Marker of “Free Radical Diseases”
(2017) · Anticancer Research · doi:10.21873/anticanres.11963 · Cited by 126
Zhang, M., Zhu, J., Zheng, Y., Guo, R., Wang, S., Mignani, S., Caminade, A.-M., Majoral, J.-P., & Shi, X. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030162 · Cited by 128
“Among the stimuli investigated for anticancer drug delivery, such as pH [12], temperature [13], and redox [14], pH has been usually investigated to trigger the drug release, since in solid tumors, the extracellular pH is more acidic (~6.”
BackgroundLiu, J., Wu, M., Pan, Y., Duan, Y., Dong, Z., Chao, Y., Liu, Z., & Liu, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908865 · Cited by 132
Mishra, P., Lee, J., Kumar, D., Louro, R. O., Costa, N. L., Pathania, D., Kumar, S. S., Lee, J., & Singh, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202108650 · Cited by 135
LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
Xiang, S., Gu, H., Jin, L., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711257115 · Cited by 129
“On the other, high levels of ROS suppress tumor growth through the inhibition of proliferation and induction of cell death (67).”
BackgroundZhou, W., Wang, X., Hu, M., Zhu, C., & Guo, Z. (2014) · Chemical Science · doi:10.1039/c4sc00384e · Cited by 134
SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation
Tsang, C. K., Chen, M., Cheng, X., Qi, Y., Chen, Y., Das, I., Li, X., Vallat, B. K., Fu, L., Qian, C.-N., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.029 · Cited by 136
“Cancer cells can be severely starved of nutrients and oxygen in an ischemic tumor microenvironment due to poor tumor vascularization (Gorrini et al., 2013; Trachootham et al., 2009), making cancer an excellent model for studying nutrient regulation of redox homeostasis in mammals.”
BackgroundKim, E.-Y., Chung, T.-W., Han, C. W., Park, S. Y., Park, K. H., Jang, S. B., & Ha, K.-T. (2019) · Scientific Reports · doi:10.1038/s41598-019-40617-3 · Cited by 125
Nestin regulates cellular redox homeostasis in lung cancer through the Keap1–Nrf2 feedback loop
Wang, J., Lu, Q., Cai, J., Wang, Y., Lai, X., Qiu, Y., Huang, Y., Ke, Q., Zhang, Y., Guan, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12925-9 · Cited by 136
Zhu, J., Xiao, T., Zhang, J., Che, H., Shi, Y., Shi, X., & van Hest, J. C. M. (2020) · ACS Nano · doi:10.1021/acsnano.0c03080 · Cited by 130
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yamada, Y., Satrialdi, S., Hibino, M., Sasaki, D., Abe, J., & Harashima, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.010 · Cited by 135
Kahroba, H., Ramezani, B., Maadi, H., Sadeghi, M. R., Jaberie, H., & Ramezani, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101211 · Cited by 133
Qu, Y., Wang, J., Ray, P. S., Guo, H., Huang, J., Shin-Sim, M., Bukoye, B. A., Liu, B., Lee, A. V., Lin, X., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43144 · Cited by 126
“As such, induction of ROS-mediated damage in cancer cells by proper pharmacological agents that either promote ROS generation or disable the cellular antioxidant system has been considered as a “radical” therapeutic strategy to preferentially kill cancer cells (9).”
BackgroundSelf-citationMedical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion
Bekeschus, S., Clemen, R., Nießner, F., Sagwal, S. K., Freund, E., & Schmidt, A. (2020) · Advanced Science · doi:10.1002/advs.201903438 · Cited by 132
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Liu, X., Xu, J., Zhou, J., & Shen, Q. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.06.010 · Cited by 133
“Cancer cells with redox adaptation survive better than other cancer cells and are thought to be associated with chemoresistance.(94) Arsenic trioxide (As2O3) induces ROS-dependent apoptosis in liver cancer cells and was adopted as the first-line treatment for acute promyelocytic leukemia (APL).”
BackgroundDai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 144
“ROS are classified as either free radicals or non-free radicals [15].”
BackgroundMaintenance of redox homeostasis by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.022 · Cited by 127
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Takaki, A., Kawai, D., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057352 · Cited by 126
“is being investigated as a cancer treatment in several clinical trials [114].”
BackgroundHatem, E., El Banna, N., & Huang, M.-E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 127
“Functional redundancy between the glutathione and Trx pathways is the biological basis for therapeutic rationales that target both redox systems to achieve synergistic anticancer effects (12, 47, 156).”
Wang, J., Luo, B., Li, X., Lu, W., Yang, J., Hu, Y., Huang, P., & Wen, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.272 · Cited by 133
“Moderate increase of ROS can promote cell differentiation and proliferation, whereas excessive ROS accumulation will cause oxidative stress and damage to cells.(5) It is well known that malignant cancer cells have increased ROS level and are more dependent on endogenous antioxidant to maintain a redox balance for cell…”
BackgroundInfluentialSelf-citationHekmatshoar, Y., Nakhle, J., Galloni, M., & Vignais, M. (2018) · Biochemical Journal · doi:10.1042/bcj20170712 · Cited by 132
Miller, B. A. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.03.002 · Cited by 135
ROS and oncogenesis with special reference to EMT and stemness
Chatterjee, R., & Chatterjee, J. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151073 · Cited by 135
Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy
Zhen, W., An, S., Wang, S., Hu, W., Li, Y., Jiang, X., & Li, J. (2021) · Advanced Materials · doi:10.1002/adma.202101572 · Cited by 130
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 156
Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer
Wang, P., Zhu, C.-F., Ma, M.-Z., Chen, G., Song, M., Zeng, Z.-L., Lu, W.-H., Yang, J., Wen, S., Chiao, P. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4125 · Cited by 132
“Indeed, activation of redox adaptation including redox-sensitive transcription factor and upregulation of antioxidant molecules has been observed in various cancers [29-32].”
Self-citationRedox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response
Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., & Huang, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.030 · Cited by 133
“It has been accepted that increasing ROS generation is likely to be a promising anticancer strategy [74].”
Phytoagents for Cancer Management: Regulation of Nucleic Acid Oxidation, ROS, and Related Mechanisms
Lee, W.-L., Huang, J.-Y., & Shyur, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/925804 · Cited by 141
“Higher levels of free form metal ions and higher levels of endogenous ROS production in cancer cells sensitizes them to phytoagent-mediated prooxidant cytotoxicity [30, 107, 108].”
Pulliam, N., Fang, F., Özeş, A., Tang, J., Adewuyi, A., Keer, H. N., Lyons, J. F., Baylin, S. B., Matei, D. E., Nakshatri, H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0204 · Cited by 126
“S5D and S5E), correlating increased PARPi sensitivity with ROS modulation (38).”
BackgroundMethodInfluentialReactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side
Prieto-Bermejo, R., Romo-González, M., Pérez-Fernández, A., Ijurko, C., & Hernández-Hernández, Á. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0797-0 · Cited by 119
“The permanent condition of the oxidative stress of leukaemic cells may offer interesting therapeutic options, and as a result the possibility of developing redox chemotherapeutics has received much more attention in recent years [135, 136].”
BackgroundWang, C., Shao, L., Pan, C., Ye, J., Ding, Z., Wu, J., Du, Q., Ren, Y., & Zhu, C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1265-2 · Cited by 136
Wu, R. P., Hayashi, T., Cottam, H. B., Jin, G., Yao, S., Wu, C. C. N., Rosenbach, M. D., Corr, M., Schwab, R. B., & Carson, D. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002890107 · Cited by 126
“06 6 ± 3 (8) 65 ± 47 (6) 11 Gossypol >50 8 ± 2 (10) 8 ± 3 (6) 1.”
BackgroundSon, Y., Wang, L., Pratheeshkumar, P., Budhraja, A., Hitron, J. A., Zhang, Z., Lee, J., & Shi, X. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.028 · Cited by 135
“Although it is commonly accepted that intracellular ROS levels are higher in cancer cells than in normal cells (Trachootham et al., 2009), some studies report the opposite phenomenon where ROS levels seem to be lower in cancer cells than in normal cells (Diehn et al.”
BackgroundJung, K., Lee, J. H., Quach, C. H. T., Paik, J.-Y., Oh, H., Park, J. W., Lee, E. J., Moon, S. H., & Lee, K.-H. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115436 · Cited by 135
“Inhibition of mTOR has also been implicated to be involved in resveratrol-mediated inhibition of glucose metabolism in cancer cells (16,18).”
BackgroundMitochondrially targeted anti-cancer agents
Biasutto, L., Dong, L., Zoratti, M., & Neužil, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.06.004 · Cited by 137
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds
Tan, C., Lu, Y., Ji, L., & Mao, Z. (2014) · Metallomics · doi:10.1039/c3mt00225j · Cited by 144
Antiradical, antimicrobial and cytotoxic activities of commercial beetroot pomace
Vulić, J. J., Ćebović, T. N., Čanadanović, V. M., Ćetković, G. S., Djilas, S. M., Čanadanović-Brunet, J. M., Velićanski, A. S., Cvetković, D. D., & Tumbas, V. T. (2013) · Food & Function · doi:10.1039/c3fo30315b · Cited by 115
Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma
Wang, Q., Wang, H., Jia, Y., Pan, H., & Ding, H. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3299-4 · Cited by 133
“Researches indicate that cancer cells have obviously higher levels of reactive oxygen species (ROS) under oxidative stress because of an imbalanced redox status compared with normal cells [2].”
Background
Metadata
- Authors
- Trachootham, D., Alexandre, J., & Huang, P.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Huang, Peng
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-05-29
- Volume
- 8
- Issue
- 7
- Pages
- 579-591
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972779889
- Cited by
- 5,452
- References
- 163
- Citations by year
- 2026: 322 · 2025: 332 · 2024: 340 · 2023: 372 · 2022: 421 · 2021: 462 · 2020: 444 · 2019: 454 · 2018: 393 · 2017: 404 · 2016: 341 · 2015: 289 · 2014: 282 · 2013: 204 · 2012: 158
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA085563, R01CA109041, CA109041, R01CA085563, R01CA100428, CA100428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- reactive oxygen species, oxidative stress, redox modulation, cancer cells, drug resistance, antioxidant capacity, anticancer agents, genomic instability
- MeSH terms
- Adaptation, Physiological, Animals, Glutathione, Humans, Neoplasms, Oxidation-Reduction, Neoplastic Stem Cells, Reactive Oxygen Species, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.